Global Financial Private Client, LLC Emergent Bio Solutions Inc. Transaction History

Global Financial Private Client, LLC

4 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2021 May 15, 2024	SELL	$56.61 - $80.46 $7,585 - $10,781	-134 Closed	0 $0
Q4 2020 May 15, 2024	SELL	$79.17 - $111.47 $3,087 - $4,347	-39 Reduced 22.54%	134 $12 Million
Q3 2020 May 15, 2024	BUY	$81.91 - $134.94 $9,255 - $15,248	113 Added 188.33%	173 $18.3 Million
Q2 2020 May 15, 2024	BUY	$54.33 - $89.52 $3,259 - $5,371	60 New	60 $4.92 Million

160

33.8M

453K

931K

Ticker EBS
Exchange NYSE
Sector Healthcare
Industry Drug Manufacturers—Specialty & Generic
Shares Outstandng 49,861,500
Market Cap $438M
Description
Emergent BioSolutions Inc., a life sciences company, focuses on the provision of preparedness and response solutions that address accidental, deliberate, and naturally occurring public health threats (PHTs) in the United States. The company's products address PHTs, which include chemical, biological, radiological, nuclear, and explosives; emergi...

Get notified when there are updates to the investment portfolio of Global Financial Private Client, LLC, based on Form 13F filings with the SEC.

Stay updated on Global Financial Private Client, LLC with notifications on news.